Natixis Investment Managers International’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Natixis Investment Managers International's BMY Position: Q3 2022 in Review
Natixis Investment Managers International sold out of Bristol-Myers Squibb (BMY) in Q3 2022, closing a stake of 55,939 shares — an estimated $4.31M sold.
Natixis Investment Managers International first reported a position in BMY in Q3 2013 and held it in 18 quarters. The position peaked at $7.7M in Q1 2022. 2,470 funds tracked by Wall St. Rank hold BMY as of Q3 2022.
- Natixis Investment Managers International reported no remaining Bristol-Myers Squibb position as of Q3 2022 after selling out during the quarter.
- Natixis Investment Managers International sold 55,939 Bristol-Myers Squibb shares in Q3 2022, an estimated $4.31M.
- Natixis Investment Managers International first reported a position in Bristol-Myers Squibb in Q3 2013 and held it in 18 quarters.
- Natixis Investment Managers International's Bristol-Myers Squibb position peaked at $7.7M in Q1 2022.
- 2,470 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2022.
Based on Natixis Investment Managers International's 13F filing for Q3 2022, filed 14 Nov 2022.